Skip to main content
Fig. 5 | BMC Infectious Diseases

Fig. 5

From: RBD-specific antibody responses after two doses of BBIBP-CorV (Sinopharm, Beijing CNBG) vaccine

Fig. 5

Effects of the age and the sex of the subject, and the time-period between the vaccination and the measurement on the probability of the lack of RBD-specific antibody production (titre below 1, left panel) and of low antibody titre (titre below 10, right panel) after two doses of the Sinopharm vaccine. 90% credible interval is shown for males, 28 days post second dose (credible intervals for the other curves are not shown for visual clarity, as they are very similar)

Back to article page